TradingKey

關於 ADMA Biologics Inc 公司

ADMA Biologics, Inc. 是一家端到端商業生物製藥公司，致力於製造、營銷和開發用於治療有感染風險的免疫缺陷患者和其他有某些傳染病風險的患者的特種生物製劑。該公司製造和營銷三種經美國食品藥品管理局 (FDA) 批准的血漿衍生生物製劑，用於治療免疫缺陷和預防某些傳染病：BIVIGAM（人靜脈注射免疫球蛋白），用於治療原發性體液免疫缺陷 (PI)；ASCENIV（人靜脈注射免疫球蛋白 - slra 10% 液體），用於治療 PI；NABI-HB（人乙肝免疫球蛋白），用於增強對乙肝病毒的免疫力。通過其子公司 ADMA BioCenters，該公司還在美國經營 FDA 批准的血漿採集者，爲其產品製造提供血漿。

公司簡介

公司代碼ADMA

公司名稱ADMA Biologics Inc

上市日期Oct 17, 2013

CEOMr. Adam S. Grossman

員工數量677

證券類型Ordinary Share

年結日Oct 17

公司地址465 State Route 17

城市RAMSEY

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編07446

電話12014785552

網址https://www.admabiologics.com/

公司代碼ADMA

上市日期Oct 17, 2013

CEOMr. Adam S. Grossman

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Adam S. Grossman

President, Chief Executive Officer, Co-Founder, Director

3.76M

-0.16%

Dr. Jerrold B. Grossman

Vice Chairman of the Board, Co-Founder

570.90K

--

Mr. Brad L. Tade

Chief Financial Officer, Treasurer

258.17K

-2.68%

Mr. Lawrence P. Guiheen

Independent Director

145.83K

-12.06%

Mr. Steven A. (Steve) Elms

Independent Chairman of the Board

87.33K

--

Mr. Eduardo Rene Salas

Independent Director

10.89K

--

Dr. Young T. Kwon, Ph.D.

Independent Director

--

Ms. Alison C. Finger

Independent Director

--

Ms. Kaitlin Kestenberg

Chief Operating Officer, Senior Vice President - Compliance

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Adam S. Grossman

President, Chief Executive Officer, Co-Founder, Director

3.76M

-0.16%

Dr. Jerrold B. Grossman

Vice Chairman of the Board, Co-Founder

570.90K

--

Mr. Brad L. Tade

Chief Financial Officer, Treasurer

258.17K

-2.68%

Mr. Lawrence P. Guiheen

Independent Director

145.83K

-12.06%

Mr. Steven A. (Steve) Elms

Independent Chairman of the Board

87.33K

--

Mr. Eduardo Rene Salas

Independent Director

10.89K

--

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

暫無數據

地區USD

名稱

營收

佔比

United States

110.73M

96.45%

International

4.07M

3.55%

業務

地區

暫無數據

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

14.32%

The Vanguard Group, Inc.

8.95%

State Street Global Advisors (US)

4.79%

Invesco Advisers, Inc.

4.06%

Geode Capital Management, L.L.C.

2.37%

Other

65.50%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

14.32%

The Vanguard Group, Inc.

8.95%

State Street Global Advisors (US)

4.79%

Invesco Advisers, Inc.

4.06%

Geode Capital Management, L.L.C.

2.37%

Other

65.50%

股東類型

持股股東

佔比

Investment Advisor

48.40%

Investment Advisor/Hedge Fund

29.25%

Hedge Fund

7.14%

Research Firm

3.34%

Individual Investor

2.56%

Private Equity

1.47%

Pension Fund

1.25%

Bank and Trust

0.42%

Sovereign Wealth Fund

0.24%

Other

5.92%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

673

224.65M

94.10%

-5.98M

2025Q1

658

218.51M

91.53%

-12.93M

2024Q4

607

216.39M

91.46%

-18.31M

2024Q3

547

221.08M

93.58%

+11.33M

2024Q2

451

193.54M

83.08%

-7.68M

2024Q1

408

187.57M

81.05%

-5.26M

2023Q4

371

181.77M

80.46%

-8.48M

2023Q3

362

185.07M

81.97%

+86.17K

2023Q2

349

179.85M

80.15%

-7.63M

2023Q1

335

188.11M

85.60%

+12.05M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

34.20M

14.32%

-829.83K

-2.37%

Mar 31, 2025

The Vanguard Group, Inc.

16.79M

7.03%

-1.36M

-7.48%

Mar 31, 2025

State Street Global Advisors (US)

11.44M

4.79%

-3.43M

-23.07%

Mar 31, 2025

Invesco Advisers, Inc.

9.69M

4.06%

+483.20K

+5.25%

Mar 31, 2025

Geode Capital Management, L.L.C.

5.67M

2.37%

+235.43K

+4.33%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

4.86M

2.04%

+191.99K

+4.11%

Mar 31, 2025

Two Sigma Investments, LP

4.84M

2.03%

-657.17K

-11.95%

Mar 31, 2025

American Century Investment Management, Inc.

4.25M

1.78%

+478.80K

+12.69%

Mar 31, 2025

Morgan Stanley & Co. LLC

4.17M

1.75%

-641.18K

-13.33%

Mar 31, 2025

Grossman (Adam S)

3.77M

1.58%

-6.00K

-0.16%

Jun 16, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Simplify Health Care ETF

5.3%

AAM Sawgrass US Small Cap Quality Growth ETF

3.58%

Invesco S&P SmallCap Health Care ETF

3.11%

Alpha Architect U.S. Quantitative Momentum ETF

1.74%

Virtus LifeSci Biotech Products ETF

1.62%

Invesco S&P SmallCap Momentum ETF

1.62%

Invesco S&P SmallCap Quality ETF

1.44%

Invesco S&P SmallCap 600 Pure Growth ETF

1.36%

SPDR S&P Biotech ETF

1.23%

First Trust Active Factor Small Cap ETF

0.93%

Simplify Health Care ETF

佔比5.3%

AAM Sawgrass US Small Cap Quality Growth ETF

佔比3.58%

Invesco S&P SmallCap Health Care ETF

佔比3.11%

Alpha Architect U.S. Quantitative Momentum ETF

佔比1.74%

Virtus LifeSci Biotech Products ETF

佔比1.62%

Invesco S&P SmallCap Momentum ETF

佔比1.62%

Invesco S&P SmallCap Quality ETF

佔比1.44%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比1.36%

SPDR S&P Biotech ETF

佔比1.23%

First Trust Active Factor Small Cap ETF

佔比0.93%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

ADMA Biologics Inc

19.915USD

ADMA Biologics Inc

19.915

概覽

公司

財務